RecruitingNot ApplicableNCT07027891

The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial

ROMIAE 2 Trial: Randomized Controlled Trial for Managing Suspicious Acute Myocardial Infarction in ED Using AI-ECG


Sponsor

CHA University

Enrollment

4,670 participants

Start Date

Jul 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study is to see whether the AI ECG assisted protocol is as safe and efficacious as conventional protocol in early triage of suspected myocardial infarction.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • chest pain
  • suspicious of acute myocardial infarction

Exclusion Criteria8

  • STEMI
  • Revisit of same symptoms within 1 week
  • traumatic chest pain
  • Pneumothorax
  • Transferred from other hospital diagnosed of AMI
  • Cardiac arrest
  • Chest pain of clearly non-cardiac etiology
  • declined to participate in the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAI-ECG

The patients in AI-ECG group would be managed with the information of the myocardial infarction risk score in AI-ECG in addition to the usual care.


Locations(12)

Asan Medical Center

Seoul, South Korea

CHA Bundang Medical Center

Seoul, South Korea

Ewha Womans University

Seoul, South Korea

Gangnam Severance Hospital

Seoul, South Korea

Hanyang University

Seoul, South Korea

Jeonbuk National University Hospital

Seoul, South Korea

Korea University Ansan Hospital

Seoul, South Korea

Korea University Guro Hospital

Seoul, South Korea

Kyung Hee University Hospital

Seoul, South Korea

Samsung Medical Center

Seoul, South Korea

Soonchunhyang University Bucheon Hospital

Seoul, South Korea

Yonsei University Wonju College of Medicine

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07027891


Related Trials